In a first analysis including the entire cohort of recruited patients (in situ and stage I–IV melanoma patients), the amount of GM‐CSF, IL4, IL‐6, IL‐10, IL‐17A, and TGF‐β detected in serum was independent of the age of the melanoma patients and it did not vary between the sexes. The gene discussed is IL17A; the disease is melanoma.